Eco R1 Capital, LLC Portfolio Holdings

Eco R1 Capital, LLC

  • $3.51 Billion
  • Q1 2024

Eco R1 Capital, LLC has filed its 13F form on May 15, 2024 for Q1 2024 where it was disclosed a total value porftolio of $3.51 Billion distributed in 59 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Apellis Pharmaceuticals, Inc. with a value of $668M, Prothena Corp Public LTD CO with a value of $287M, Arvinas, Inc. with a value of $278M, Sarepta Therapeutics, Inc. with a value of $249M, and Crinetics Pharmaceuticals, Inc. with a value of $195M.

Examining the 13F form we can see an increase of $37.5M in the current position value, from $3.47B to 3.51B.

Eco R1 Capital, LLC is based out at San Francisco, CA

Below you can find more details about Eco R1 Capital, LLC portfolio as well as his latest detailed transactions.

Portfolio value $3.51 Billion
Healthcare: $3.5 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$4.21B
$668 Million 19.04% of portfolio
11,357,425
Q1 2024 Added 1.65%
$968M
$287 Million 8.18% of portfolio
11,584,280
Q1 2022 Added 2.66%
$1.42B
$278 Million 7.92% of portfolio
6,726,491
Q4 2023 Added 23.04%
$13.8B
$249 Million 7.09% of portfolio
1,919,835
Q1 2024 Added 130.5%
$2.41B
$195 Million 5.55% of portfolio
4,155,375
Q1 2024 Added 106.48%
$1.63B
$185 Million 5.29% of portfolio
5,756,268
Q2 2023 Added 35.61%
$1.38B
$124 Million 3.53% of portfolio
5,806,871
Q2 2023 Reduced 12.53%
$6.69B
$122 Million 3.48% of portfolio
1,013,952
Q4 2023 Added 175.22%
$1.13B
$118 Million 3.36% of portfolio
5,330,416
Q1 2024 Added 0.91%
$2.63B
$111 Million 3.16% of portfolio
5,991,479
Q1 2022 Added 95.76%
$756M
$106 Million 3.02% of portfolio
13,330,736
Q4 2023 Added 52.85%
$147M
$95.7 Million 2.73% of portfolio
3,879,415
Q4 2023 New
$4.21B
$94.7 Million 2.7% of portfolio
1,389,276
Q1 2024 New
$195M
$86.8 Million 2.47% of portfolio
19,364,688
Q3 2023 New
$1.31B
$83.9 Million 2.39% of portfolio
2,384,384
Q1 2024 Added 1,028.64%
$634M
$69.9 Million 1.99% of portfolio
19,209,643
Q3 2023 Added 38.23%
$280M
$47 Million 1.34% of portfolio
3,418,068
Q1 2022 Reduced 1.47%
$160M
$43.3 Million 1.23% of portfolio
27,404,070
Q1 2024 New
$111M
$39.7 Million 1.13% of portfolio
5,000,000
Q2 2023 New
$306M
$36.5 Million 1.04% of portfolio
3,917,546
Q1 2024 Added 1.71%
$524M
$30 Million 0.86% of portfolio
3,182,444
Q4 2023 Added 6.71%
$528M
$27.3 Million 0.78% of portfolio
1,999,249
Q1 2024 Added 79.3%
$1.73B
$27.3 Million 0.78% of portfolio
650,000
Q1 2024 New
$276M
$24.8 Million 0.71% of portfolio
6,145,861
Q1 2024 Reduced 12.15%
$375M
$24.4 Million 0.7% of portfolio
4,056,548
Q2 2022 Reduced 29.31%
$1.14B
$22.8 Million 0.65% of portfolio
1,250,385
Q1 2024 Reduced 64.21%
$288M
$21.6 Million 0.62% of portfolio
2,000,000
Q1 2024 New
$635M
$20.8 Million 0.59% of portfolio
900,000
Q4 2023 New
$4.48B
$20.5 Million 0.58% of portfolio
300,000
Q1 2024 New
$4.79B
$20 Million 0.57% of portfolio
75,000
Q1 2024 New
$2.13B
$19.3 Million 0.55% of portfolio
757,576
Q1 2024 New
$54.2M
$18.7 Million 0.53% of portfolio
6,117,400
Q1 2022 Added 0.58%
$293M
$16.6 Million 0.47% of portfolio
1,250,000
Q4 2023 New
$1.18B
$12.4 Million 0.35% of portfolio
187,500
Q1 2024 New
$1.83B
$12.1 Million 0.35% of portfolio
427,039
Q1 2024 New
$84.6M
$10.9 Million 0.31% of portfolio
9,195,404
Q3 2023 New
$122M
$8.49 Million 0.24% of portfolio
1,613,600
Q1 2024 New
$166M
$8.33 Million 0.24% of portfolio
2,046,867
Q2 2023 Added 4.61%
$67M
$8.58 Million 0.24% of portfolio
11,294,585
Q1 2024 New
$802M
$7.02 Million 0.2% of portfolio
10,167,043
Q1 2024 Added 0.99%
$118M
$6.61 Million 0.19% of portfolio
2,884,357
Q1 2024 Reduced 3.21%
$13.9M
$6.26 Million 0.18% of portfolio
6,389,468
Q4 2023 Added 61.83%
$560M
$4.96 Million 0.14% of portfolio
500,000
Q1 2024 New
$492M
$4.9 Million 0.14% of portfolio
700,000
Q1 2024 New
$30.5M
$3.26 Million 0.09% of portfolio
4,595,024
Q2 2023 Added 85.77%
$73.9M
$963,000 0.03% of portfolio
566,879
Q4 2023 New
Kyverna Therapeutics Inc
-
$0 0.0% of portfolio
-
Q1 2024 New
Lenz Therapeutics Inc
-
$0 0.0% of portfolio
-
Q1 2024 New
Neumora Therapeutics Inc.
-
$0 0.0% of portfolio
-
Q3 2023 New

Summary

  • Portfolio
  • No. of Stocks 59
  • Current Value $3.51 Billion
  • Prior Value $3.47 Billion
  • Filing
  • Period Q1 2024
  • Filing Date May 15, 2024
  • Form Type 13F-HR
  • Activity in Q1 2024
  • New Purchases 16 stocks
  • Additional Purchases 8 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 3 stocks
Track This Portfolio

Track Eco R1 Capital, LLC Portfolio

Follow Eco R1 Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eco R1 Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eco R1 Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email